stockrow
Friday 6 November 2026
Export DFTX’s income statement to Excel — free account
Definium Therapeutics, Inc.
DFTX Healthcare Biotechnology
- EPS
- −188.0%
- Free cash flow
- −78.3%
- Total debt
- −11.5%
Quarter to June 2026, against a year earlier
33.27
2.91
+9.58%
Follow DFTX
Alert me
Definium Therapeutics, Inc. (DFTX) Current ratio
Definium Therapeutics, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 6.9×, up 0.7× from fiscal 2025 (6.3×). Over the past ten years it has ranged from 1.8× (fiscal 2016) to 27.1× (fiscal 2020); the current reading is higher than 30% of that period. That is above the Biotechnology industry median of 5.0× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 6.3× | (13.27%) |
| FY2024 | 7.2× | 125.04% |
| FY2023 | 3.2× | (60.54%) |
| FY2022 | 8.2× | (38.08%) |
| FY2021 | 13.2× | (51.35%) |
| FY2020 | 27.1× | 83.63% |
| FY2019 | 14.8× | (39.06%) |
| FY2018 | 24.2× | 9.90% |
| FY2017 | 22.0× | 1,121.58% |
| FY2016 | 1.8× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 6.9× | 48.07% |
| Mar 2026 | 4.7× | (25.37%) |
| Dec 2025 | 6.3× | 90.53% |
| Sep 2025 | 3.3× | (33.78%) |
| 24 more quarters | Free account |
Against its own ten years
Low 1.8×
High 27.1×
Ten-year median
10.7×
Current reading's percentile
30
Current ratio against peers
| Company | Current ratio |
|---|---|
| DNTH Dianthus Therapeutics, Inc. compare | 30.0× |
| XENE Xenon Pharmaceuticals Inc. compare | 21.0× |
| RLAY Relay Therapeutics, Inc. compare | 14.6× |
| ABCL AbCellera Biologics Inc. compare | 12.8× |
| EWTX Edgewise Therapeutics, Inc. compare | 12.3× |
| ERAS Erasca, Inc. compare | 8.3× |
| DFTX Definium Therapeutics, Inc. | 6.9× |
| ACAD ACADIA Pharmaceuticals Inc. compare | 3.8× |
| LEGN Legend Biotech Corporation Sponsored ADR compare | 3.0× |
| Biotechnology industry median | 5.0× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)